Stereospecific method for separation and quantification of Ezetimibe and its stereoisomers using ultra-performance convergence chromatography (UPC2) | Synapse
March 3, 2026
Stereospecific method for separation and quantification of Ezetimibe and its stereoisomers using ultra-performance convergence chromatography (UPC2)
Key Points
The method effectively separates ezetimibe and its stereoisomers, allowing for accurate quantification in formulations.
An impressive resolution of 10.5 between stereoisomers showcases the method's high efficiency and performance.
Analysis employed ultra-performance convergence chromatography, providing rapid results while maintaining high analytical quality.
This approach supports the improvement of drug formulation by allowing clear identification of ezetimibe stereoisomers, critical for dosage accuracy.